Thomson sells data unit for $1.25B

Share this article:

Private-equity firm Veritas Capital will buy the healthcare business of Thomson Reuters for $1.25 billion in cash.

The sale, which was announced in late April, was expected to close in a few months. Thomson Reuters had re-launched a sales process for the unit earlier this year.

The healthcare business provides data, analytics and other services to companies, government agencies and healthcare professionals. Its brands include MarketScan, Advantage Suite, Micromedex, CareDiscovery and ActionOI, coupled with expert services and analysis.

CEO Mike Boswood will continue to be in charge of the business, said Veritas Capital's chairman, Robert McKeon, in a statement.
Share this article:
close

Next Article in Agency Gallery

Email Newsletters

More in Agency Gallery

Private View: Creating Compelling Experiences

Private View: Creating Compelling Experiences

In today's multi-channel environment, game-changing ideas blend creativity and sensory ideation to create a meaningful customer experience

Putting consumers at the center of your universe

Putting consumers at the center of your universe

The question should be: How do you simplify and identify the moments that mean the most to customers?

Did "pay-to-play" confab help Zohydro approval?

Did "pay-to-play" confab help Zohydro approval?

US senators Joe Manchin (D-WV) and David Vitter (R-LA) are asking whether a "pay-to-play" meeting between drug industry executives and FDA officials influenced the agency's approval of Zohydro